flecainide was administered in oral doses individually adjusted to suppress all spontaneous ventricular tachycardia and 80 % of ventricular premature complexes on 24 hour ambulatory ( holter ) electrocardiography .
C0016229
flecainide
C0042514
ventricular tachycardia